HRTX — Heron Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Heron Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	391	208	158	84.9	80.4
Net Total Accounts Receivable
Net Total Receivables	39.9	41.9	35.5	52	60.1
Total Inventory
Prepaid Expenses
Total Current Assets	479	314	254	205	189
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	33.4	39	33.6	29.8	25.6
Other Long Term Assets
Total Assets	513	354	306	251	223
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	96.7	103	71.1	82.4	79.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	109	117	228	237	256
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	404	236	77.6	13.6	-34
Total Liabilities & Shareholders' Equity	513	354	306	251	223
Total Common Shares Outstanding